Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BMN NASDAQ:IRON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMNBlackrock 2037 Municipal Target Term Trust$24.97-0.1%$24.48$23.04▼$26.14N/AN/A12,886 shs19,181 shsIRONDisc Medicine$59.94-0.7%$58.81$30.82▼$68.73$2.08B0.77395,690 shs318,138 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMNBlackrock 2037 Municipal Target Term Trust+1.73%+3.18%+3.59%+1.69%-0.28%IRONDisc Medicine-2.54%-1.73%+3.98%+18.64%+16.62%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMNBlackrock 2037 Municipal Target Term Trust$24.97-0.1%$24.48$23.04▼$26.14N/AN/A12,886 shs19,181 shsIRONDisc Medicine$59.94-0.7%$58.81$30.82▼$68.73$2.08B0.77395,690 shs318,138 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMNBlackrock 2037 Municipal Target Term Trust+1.73%+3.18%+3.59%+1.69%-0.28%IRONDisc Medicine-2.54%-1.73%+3.98%+18.64%+16.62%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBMNBlackrock 2037 Municipal Target Term Trust 0.00N/AN/AN/AIRONDisc Medicine 3.09Buy$98.3063.68% UpsideCurrent Analyst Ratings BreakdownLatest ARK, SML, IRON, and BMN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/18/2025IRONDisc MedicineMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$85.00 ➝ $90.007/21/2025IRONDisc MedicineWedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$90.007/21/2025IRONDisc MedicineTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$86.007/3/2025IRONDisc MedicineMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$85.007/3/2025IRONDisc MedicineHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$118.006/17/2025IRONDisc MedicineHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$118.006/16/2025IRONDisc MedicineWedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$90.006/11/2025IRONDisc MedicineRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageStrong-Buy$89.00(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBMNBlackrock 2037 Municipal Target Term Trust$738.41KN/AN/AN/AN/AN/AIRONDisc MedicineN/AN/AN/AN/A$14.85 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBMNBlackrock 2037 Municipal Target Term TrustN/AN/A0.00∞N/AN/AN/AN/AN/AIRONDisc Medicine-$109.36M-$4.47N/AN/AN/AN/A-26.60%-24.58%11/11/2025 (Estimated)Latest ARK, SML, IRON, and BMN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025IRONDisc Medicine-$1.17-$1.58-$0.41-$1.58N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBMNBlackrock 2037 Municipal Target Term Trust$0.652.60%N/AN/AN/AIRONDisc MedicineN/AN/AN/AN/AN/ALatest ARK, SML, IRON, and BMN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/2/2025BMNBlackrock 2037 Municipal Target Term Trustmonthly$0.09384.62%9/15/20259/15/202510/1/20258/1/2025BMNBlackrock 2037 Municipal Target Term Trustmonthly$0.09384.7%8/15/20258/15/20259/2/20257/1/2025BMNBlackrock 2037 Municipal Target Term Trustmonthly$0.09384.5%7/15/20257/15/20257/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AIRONDisc Medicine0.0532.1132.11Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBMNBlackrock 2037 Municipal Target Term TrustN/AIRONDisc Medicine83.70%Insider OwnershipCompanyInsider OwnershipBMNBlackrock 2037 Municipal Target Term TrustN/AIRONDisc Medicine3.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AN/AIRONDisc Medicine3034.77 million33.50 millionNot OptionableARK, SML, IRON, and BMN HeadlinesRecent News About These CompaniesDisc Medicine, Inc. (IRON) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)2 hours ago | seekingalpha.comTrexquant Investment LP Decreases Holdings in Disc Medicine, Inc. $IRONSeptember 10 at 3:27 AM | marketbeat.comAdage Capital Partners GP L.L.C. Sells 50,000 Shares of Disc Medicine, Inc. $IRONSeptember 8 at 4:57 AM | marketbeat.comNorthern Trust Corp Purchases 21,796 Shares of Disc Medicine, Inc. $IRONSeptember 8 at 3:21 AM | marketbeat.comDisc Medicine, Inc. $IRON Shares Sold by Raymond James Financial Inc.September 8 at 3:20 AM | marketbeat.comEventide Asset Management LLC Buys New Position in Disc Medicine, Inc. $IRONSeptember 7 at 6:05 AM | marketbeat.comCheckpoint Capital L.P. Acquires 58,311 Shares of Disc Medicine, Inc. $IRONSeptember 6, 2025 | marketbeat.com1,577,106 Shares in Disc Medicine, Inc. $IRON Acquired by RA Capital Management L.P.September 4, 2025 | marketbeat.comDisc Medicine Earns Relative Strength Rating Upgrade; Hits Key BenchmarkSeptember 4, 2025 | msn.comGhisallo Capital Management LLC Purchases Shares of 25,000 Disc Medicine, Inc. $IRONSeptember 2, 2025 | marketbeat.comArmistice Capital LLC Has $21.64 Million Stock Holdings in Disc Medicine, Inc. $IRONSeptember 2, 2025 | marketbeat.comDisc Medicine, Inc. $IRON Stock Holdings Trimmed by Paradigm Biocapital Advisors LPSeptember 2, 2025 | marketbeat.comWalleye Capital LLC Trims Position in Disc Medicine, Inc. $IRONSeptember 2, 2025 | marketbeat.comRafferty Asset Management LLC Has $1.69 Million Position in Disc Medicine, Inc. $IRONSeptember 2, 2025 | marketbeat.comSiren L.L.C. Invests $53.21 Million in Disc Medicine, Inc. $IRONAugust 31, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Sells 36,383 Shares of Disc Medicine, Inc. $IRONAugust 29, 2025 | marketbeat.comQuantbot Technologies LP Grows Stake in Disc Medicine, Inc. $IRONAugust 29, 2025 | marketbeat.comNuveen LLC Buys New Position in Disc Medicine, Inc. $IRONAugust 28, 2025 | marketbeat.comDisc Medicine, Inc. $IRON Stock Position Raised by Charles Schwab Investment Management Inc.August 28, 2025 | marketbeat.comStocks To Watch: Disc Medicine Sees Relative Strength Rating Jump To 81August 27, 2025 | msn.comKevin Bitterman Sells 2,287 Shares of Disc Medicine (NASDAQ:IRON) StockAugust 27, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Case for Buying NVIDIA Stock Ahead of the Robotics SurgeBy Thomas Hughes | August 20, 2025Medtronic: The Opportunity Gets Healthier for Income InvestorsBy Thomas Hughes | August 19, 2025Jackson Hole 2025: Fed’s Signal Could Shift Stocks FastBy Chris Markoch | August 20, 2025Target: Missing the Mark in 2025—Downtrend May ContinueBy Thomas Hughes | August 20, 2025Alphabet’s Breakout Potential: From Laggard to AI LeaderBy Ryan Hasson | August 22, 2025ARK, SML, IRON, and BMN Company DescriptionsBlackrock 2037 Municipal Target Term Trust NYSE:BMN$24.97 -0.03 (-0.11%) Closing price 03:59 PM EasternExtended Trading$25.25 +0.28 (+1.11%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Blackrock 2037 Municipal Target Term Trust is an close-ended fixed income mutual fund launched by Blackrock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in fixed income markets. The fund primarily invests in n investment grade municipal securities that are rated BBB- or above by S&P and Fitch or Baa3 or above by Moody's. Blackrock 2037 Municipal Target Term Trust is domiciled in the United States.Disc Medicine NASDAQ:IRON$59.94 -0.40 (-0.66%) Closing price 04:00 PM EasternExtended Trading$59.98 +0.04 (+0.07%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Celsius Stock Surges After Blowout Earnings and Pepsi Deal Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Alphabet Stock’s Weakness Was Wall Street’s Opportunity Should You Buy Figma Stock After Its 55% Post-IPO Drop? Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead Forget QQQ: This ETF Marries the Magnificent 7 and Communications Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
